Abstract | PURPOSE: DESIGN: Interventional case report. METHODS: RESULTS: Topical tacrolimus 0.03% ointment (Protopic; Fujisawa, Dublin, Ireland) was applied to the eyelid skin twice daily. An improvement of eyelid inflammation was observed while eczematous skin lesions and erosions were resolved within 15 days. After 6 months of continued topical tacrolimus treatment, there was no evidence of atopic dermatitis recurrence. During this period IOP remained controlled without any evidence of deregulation. CONCLUSIONS:
|
Authors | George D Kymionis, Miltiadis K Tsilimbaris, Olga E Iliaki, Emmanuelle Christodoulakis, Charalambos S Siganos, Ioannis G Pallikaris |
Journal | Cornea
(Cornea)
Vol. 23
Issue 8
Pg. 828-30
(Nov 2004)
ISSN: 0277-3740 [Print] United States |
PMID | 15502487
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Glucocorticoids
- Immunosuppressive Agents
- Tacrolimus
|
Topics |
- Administration, Topical
- Dermatitis, Atopic
(complications, drug therapy)
- Eyelid Diseases
(complications, drug therapy)
- Glaucoma, Open-Angle
(complications, drug therapy)
- Glucocorticoids
(therapeutic use)
- Humans
- Immunosuppressive Agents
(therapeutic use)
- Intraocular Pressure
- Male
- Middle Aged
- Tacrolimus
(therapeutic use)
|